ocal radiotherapy followed by maintenance combination immunotherapy for advanced non-small-cell lung cancer patients whose initial combination immunotherapy failed with oligo-progression: multicenter, phase II study
Phase 2
- Conditions
- non-small-cell lung cancer
- Registration Number
- JPRN-UMIN000041778
- Lead Sponsor
- ational Hospital Organization Shikoku Cancer Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 3
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with serious complications or history are excluded.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1-year survival rate
- Secondary Outcome Measures
Name Time Method Overall survival, progression-free survival, safety, post-treatment status